From owner-7tms_r@net.bio.net Thu Oct 02 23:00:00 1997
Path: biosci!biosci!not-for-mail
From: RABond@UH.EDU
Newsgroups: bionet.molbio.proteins.7tms_r
Subject: Post-Doctoral position
Date: 3 Oct 1997 03:32:46 -0700
Organization: BIOSCI International Newsgroups for Molecular Biology
Lines: 21
Sender: daemon@net.bio.net
Approved: lfk@gcrdb.uthscsa.edu
Distribution: world
Message-ID: <612hke$dt3@net.bio.net>
NNTP-Posting-Host: net.bio.net

                        POST-DOCTORAL POSITION AVAILABLE:
The primary interest of the lab is receptor theory for GPCRs using the
Beta2-adrenoceptor as the prototype.  We have been primarily performing
whole animal and isolated tissue studies from transgenic and knockout mice
in collaboration with Bob Lefkowitz.  We would like to expand into
transfected cell systems and are seeking people with experience in
transfection of receptors, radioligand binding assays and second messenger
assays.  The position is available for 2 or 3 years.  Please contact:
Richard A. Bond, Ph.D.
University of Houston
4800 Calhoun
Houston, TX  77204-5515
phone: (713) 743-1210 or (713) 743-1219
fax: (713) 743-1229
e-mail: RABond@UH.Edu


Richard A. Bond, Ph.D.: Department of Pharmacological and Pharmaceutical
Sciences, University of Houston, 4800 Calhoun, Houston, Texas 77204-5515. 
E-mail: RABond@UH.edu  telephones: office: (713) 743-1210, lab: (713)
743-1219 fax: (713) 743-1229.  

From owner-7tms_r@net.bio.net Thu Oct 02 23:00:00 1997
Path: biosci!biosci!not-for-mail
From: Gennady PODA <poda@violet.incm.u-nancy.fr>
Newsgroups: bionet.molbio.proteins.7tms_r
Subject: 7tm_r: chemokine receptor dimerization summary
Date: 3 Oct 1997 03:33:28 -0700
Organization: BIOSCI International Newsgroups for Molecular Biology
Lines: 113
Sender: daemon@net.bio.net
Approved: lfk@gcrdb.uthscsa.edu
Distribution: world
Message-ID: <612hlo$dtr@net.bio.net>
NNTP-Posting-Host: net.bio.net


Dear Netters,

I have nothing to add about this problem. All the answers I got were
people did not come across any experimental confirmation about the
dimerization of the chemokine receptors. Since the topic is quite hot so I
could conclude that the people who are doing now such experiments mostly
keep silence unless the results got published. So we have to wait a bit. 

Thanks a lot for everybody who answered.

With best wishes,

Gennady




The answers are here:



From: Vinnie Terranova <bjmarg@welchlink.welch.jhu.edu>
Subject: Re: Dimerization of chemokine receptors

Actually, I am setting up to examine exactly this phenomenon.  As soon as
I get some results, I could e-mail you.

On Tue, 30 Sep 1997, Gennady PODA wrote:

> 
> Dear experimentalists,
> 
> previously the phemonenon of dimerization of GPCRs has been discussed in
> short in this newsgroup. Now I am wondering about a more particular question.
> 
> Has any one seen (done) an experimental confirmation that chemokine
> receptors (any of them) can (or can not) form dimers? I could not find in
> the literature any of such references. I will summarize the answers. 
> Thanks a lot in advance for participation.
> 
> With best wishes,
> 
> Gennady
> 
> 
> 
> 
> *******************************************************************
> *  Dr Gennady Poda                                                *
> *******************************************************************
> *  Laboratoire de Chimie theorique (UA 510 au CNRS)               *
> *  Universite Henri Poincare, Nancy-I                             *
> *  Faculte des Sciences - Domaine scientifique Victor Grignard    *
> *  BP 239 - 54506 Vandoeuvre-les-Nancy Cedex France               *
> *                                                                 *
> *  Tel (lab) + 33 (0)3.83.91.20.50  E-mail  poda@incm.u-nancy.fr  *
> *  FAX       + 33 (0)3.83.91.25.30          gpoda@loria.fr        *
> *******************************************************************
> 

From: Stanley Krystek <krystek@alcor.bms.com>
Subject: chemokine receptors


I have not seen anyone modeling the dimerization
of these receptors and would be interested in any
responses that you get concerning experimental 
evidence.

thanks 

stan krystek

 Stanley R. Krystek, Jr., Ph.D.      
 Bristol-Myers Squibb Pharmaceutical Research Institute 
 Department of Macromolecular Modeling
 P.O. Box 4000, Room H.3812, Princeton, N.J.  08543-4000
 (609) 252-4100  FAX: (609) 252-6030 
 INTERNET:  krystek@bms.com 



From: hoebeke@univ-tours.fr
Subject: Re: Dimerization of chemokine receptors

Dear Gennady,

As far as I know, nobody as yet gas discussed dimerisation of chemokine
receptors.

Yours,
Johan Hoebeke









*******************************************************************
*  Dr Gennady Poda                                                *
*******************************************************************
*  Laboratoire de Chimie theorique (UA 510 au CNRS)               *
*  Universite Henri Poincare, Nancy-I                             *
*  Faculte des Sciences - Domaine scientifique Victor Grignard    *
*  BP 239 - 54506 Vandoeuvre-les-Nancy Cedex France               *
*                                                                 *
*  Tel (lab) + 33 (0)3.83.91.20.50  E-mail  poda@incm.u-nancy.fr  *
*  FAX       + 33 (0)3.83.91.25.30          gpoda@loria.fr        *
*******************************************************************

From owner-7tms_r@net.bio.net Thu Oct 02 23:00:00 1997
Path: biosci!biosci!not-for-mail
From: Gert.Vriend@EMBL-Heidelberg.de
Newsgroups: bionet.molbio.proteins.7tms_r
Subject: which cells express which receptors?
Date: 3 Oct 1997 10:40:39 -0700
Organization: BIOSCI International Newsgroups for Molecular Biology
Lines: 18
Sender: daemon@net.bio.net
Approved: lfk@gcrdb.uthscsa.edu
Distribution: world
Message-ID: <613amn$5k3@net.bio.net>
NNTP-Posting-Host: net.bio.net

Dear GPCR friends,

There are regularly questions in this news group regarding receptors
endogenously expressed in certain cell-lines. We discussed this topic
earlier this year and many people sent data to Agi Schonbrunn who made
a good WWW based list.

The pointer to that data is:
http://www.biomedcomp.com/GPCR.html
(also reachable from the "pointers to GPCR sites" list on http://www.gpcr.org)

Perhaps everybody should take a look if they have data available to them
that is not yet included in this list (the last update was june 9-th, and
some discoveries must have been made since that time....).

Greetings

Gert Vriend

From owner-7tms_r@net.bio.net Thu Oct 02 23:00:00 1997
Path: biosci!biosci!not-for-mail
From: Steve Alexander <steve.alexander@nottingham.ac.uk>
Newsgroups: bionet.molbio.proteins.7tms_r
Subject: Re: adrenoreceptors
Date: 3 Oct 1997 10:41:28 -0700
Organization: University of Nottingham
Lines: 46
Sender: daemon@net.bio.net
Approved: lfk@gcrdb.uthscsa.edu
Distribution: world
Message-ID: <613ao8$5p1@net.bio.net>
References: <612k4r$ipr@net.bio.net>
Reply-To: steve.alexander@nottingham.ac.uk.nospam
NNTP-Posting-Host: net.bio.net

BALWINDER SAMBI wrote:
> 
> would appreciate any information on cells which endogenously express
> either the alpha 2 or beta 2adrenoreceptor

From my database records, alpha2 's are endogenously expressed in:

PC12 rat phaeochromocytoma (Gatti et al. (1988) BiochemJ 255,753-760)

HT 29 (Jones and Bylund. (1988)JBiolChem 263,14236-14244)

NG108-15 murine neuroblastoma rat glioma hybrid (Louie et al.
(1990)JPharmacolExpTher 253,401-407; Strassheim and Malbon.
(1994)JBiolChem 269,14307-14313)

SH-SY5Y human neuroblastoma (Lameh et al.
(1992)EurJPharmacol-MolPharmacol 227,19-24)

SK-N-BE human neuroblastoma (Namir et al. (1997)JNeurochem 68,1764-1772)

NAL-GT human neuroblastoma (Lambert. (1995)NeurosciLett 183,4-7)

beta2 's are endogenously expressed in:

C6 rat glioma (Ruck et al. (1990)BiochemPharmacol 40,2371-2375; Hosoda
et al. (1995)MolPharmacol 48,206-211; Zhong and Minneman.
(1995)JPharmacolExpTher 272,1088-1094; McCrea and Hill.
(1996)MolPharmacol 49,927-937)

B50 mouse neuroblastoma (Ruck et al. (1990)BiochemPharmacol
40,2371-2375; McCrea and Hill. (1993)BrJPharmacol 110,619-626)

U937 human promonocytic (Pauleugene et al. (1993)MolecularImmunology
30,157-164)

S49 mouse lymphoma (Clark et al. (1993)JBiolChem 268,3245-3250; Post et
al. (1996)JBiolChem 271,895-900)


I'm sure that there must be others, though.
- -- 
:::::::::::::::::::::::::::::::::::::::::::::::
Steve Alexander, Biomedical Sciences,
Nottingham NG7 2UH, UK
WWW http://www.nottingham.ac.uk/biomedsci/
%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%

From owner-7tms_r@net.bio.net Thu Oct 02 23:00:00 1997
Path: biosci!biosci!not-for-mail
From: Gennady PODA <poda@violet.incm.u-nancy.fr>
Newsgroups: bionet.molbio.proteins.7tms_r
Subject: 7tm_r: chemokine receptor dimerization summary
Date: 3 Oct 1997 03:39:02 -0700
Organization: BIOSCI International Newsgroups for Molecular Biology
Lines: 113
Sender: daemon@net.bio.net
Approved: lfk@gcrdb.uthscsa.edu
Distribution: world
Message-ID: <612i06$ehm@net.bio.net>
NNTP-Posting-Host: net.bio.net


Dear Netters,

I have nothing to add about this problem. All the answers I got were
people did not come across any experimental confirmation about the
dimerization of the chemokine receptors. Since the topic is quite hot so I
could conclude that the people who are doing now such experiments mostly
keep silence unless the results got published. So we have to wait a bit. 

Thanks a lot for everybody who answered.

With best wishes,

Gennady




The answers are here:



From: Vinnie Terranova <bjmarg@welchlink.welch.jhu.edu>
Subject: Re: Dimerization of chemokine receptors

Actually, I am setting up to examine exactly this phenomenon.  As soon as
I get some results, I could e-mail you.

On Tue, 30 Sep 1997, Gennady PODA wrote:

> 
> Dear experimentalists,
> 
> previously the phemonenon of dimerization of GPCRs has been discussed in
> short in this newsgroup. Now I am wondering about a more particular question.
> 
> Has any one seen (done) an experimental confirmation that chemokine
> receptors (any of them) can (or can not) form dimers? I could not find in
> the literature any of such references. I will summarize the answers. 
> Thanks a lot in advance for participation.
> 
> With best wishes,
> 
> Gennady
> 
> 
> 
> 
> *******************************************************************
> *  Dr Gennady Poda                                                *
> *******************************************************************
> *  Laboratoire de Chimie theorique (UA 510 au CNRS)               *
> *  Universite Henri Poincare, Nancy-I                             *
> *  Faculte des Sciences - Domaine scientifique Victor Grignard    *
> *  BP 239 - 54506 Vandoeuvre-les-Nancy Cedex France               *
> *                                                                 *
> *  Tel (lab) + 33 (0)3.83.91.20.50  E-mail  poda@incm.u-nancy.fr  *
> *  FAX       + 33 (0)3.83.91.25.30          gpoda@loria.fr        *
> *******************************************************************
> 

From: Stanley Krystek <krystek@alcor.bms.com>
Subject: chemokine receptors


I have not seen anyone modeling the dimerization
of these receptors and would be interested in any
responses that you get concerning experimental 
evidence.

thanks 

stan krystek

 Stanley R. Krystek, Jr., Ph.D.      
 Bristol-Myers Squibb Pharmaceutical Research Institute 
 Department of Macromolecular Modeling
 P.O. Box 4000, Room H.3812, Princeton, N.J.  08543-4000
 (609) 252-4100  FAX: (609) 252-6030 
 INTERNET:  krystek@bms.com 



From: hoebeke@univ-tours.fr
Subject: Re: Dimerization of chemokine receptors

Dear Gennady,

As far as I know, nobody as yet gas discussed dimerisation of chemokine
receptors.

Yours,
Johan Hoebeke









*******************************************************************
*  Dr Gennady Poda                                                *
*******************************************************************
*  Laboratoire de Chimie theorique (UA 510 au CNRS)               *
*  Universite Henri Poincare, Nancy-I                             *
*  Faculte des Sciences - Domaine scientifique Victor Grignard    *
*  BP 239 - 54506 Vandoeuvre-les-Nancy Cedex France               *
*                                                                 *
*  Tel (lab) + 33 (0)3.83.91.20.50  E-mail  poda@incm.u-nancy.fr  *
*  FAX       + 33 (0)3.83.91.25.30          gpoda@loria.fr        *
*******************************************************************

From owner-7tms_r@net.bio.net Thu Oct 02 23:00:00 1997
Path: biosci!biosci!not-for-mail
From: BALWINDER SAMBI <samb-bs0@paisley.ac.uk>
Newsgroups: bionet.molbio.proteins.7tms_r
Subject: adrenoreceptors
Date: 3 Oct 1997 04:15:39 -0700
Organization: University of Paisley
Lines: 2
Sender: daemon@net.bio.net
Approved: lfk@gcrdb.uthscsa.edu
Distribution: world
Message-ID: <612k4r$ipr@net.bio.net>
NNTP-Posting-Host: net.bio.net

would appreciate any information on cells which endogenously express
either the alpha 2 or beta 2adrenoreceptor

From owner-7tms_r@net.bio.net Sun Oct 05 23:00:00 1997
Path: biosci!biosci!not-for-mail
From: CES@novo.dk (CES)
Newsgroups: bionet.molbio.proteins.7tms_r
Subject: Direct photoaffinity labelling
Date: 6 Oct 1997 06:04:35 -0700
Organization: BIOSCI International Newsgroups for Molecular Biology
Lines: 13
Sender: daemon@net.bio.net
Approved: lfk@gcrdb.uthscsa.edu
Distribution: world
Message-ID: <61anl3$bu9@net.bio.net>
NNTP-Posting-Host: net.bio.net

     Dear 7tm netters.
     
     Does anyone have a protocol for UV mediated photoaffinity labelling by 
     a 125I-labelled ligand of a target protein? The ligand in question has 
     no photo-reactive groups like azido, but just contains a 
     (photo-labile?) alkyliodide.
     Please reply to
     
     ces@novo.dk
     Carsten E. Stidsen
     Molecular Pharmacology
     Novo Nordisk A/S
     Denmark

From owner-7tms_r@net.bio.net Mon Oct 06 23:00:00 1997
Path: biosci!biosci!not-for-mail
From: "A. Schonbrunn" <aschonb@farmr1.med.uth.tmc.edu>
Newsgroups: bionet.molbio.proteins.7tms_r
Subject: endogenous receptors
Date: 7 Oct 1997 14:36:04 -0700
Organization: BIOSCI International Newsgroups for Molecular Biology
Lines: 13
Sender: daemon@net.bio.net
Approved: lfk@gcrdb.uthscsa.edu
Distribution: world
Message-ID: <61ea04$8hj@net.bio.net>
NNTP-Posting-Host: net.bio.net

Dear all:

I have just updated the endogenous receptor list posted at:

http://www.biomedcomp.com/GPCR.html

If you have a favorite cell line that you would like to have included and,
better yet, can e-mail me information of which receptors are expressed, I
will continue to add to the list.

Thanks for the input from those who wrote previously.

Agi Schonbrunn

From owner-7tms_r@net.bio.net Sat Oct 11 23:00:00 1997
Path: biosci!biosci!not-for-mail
From: daemon@net.bio.net
Newsgroups: bionet.molbio.proteins.7tms_r
Subject: BioScience Information
Date: 12 Oct 1997 09:30:44 -0700
Organization: The Science Guide
Lines: 90
Approved: lfk@gcrdb.uthscsa.edu
Distribution: world
Message-ID: <61qtvk$3d9@net.bio.net>
Reply-To: news@scienceguide.com
NNTP-Posting-Host: net.bio.net
Keywords: Science Directory, Conference Info, Science News, Medical I=

Announcing the SCIENCE GUIDE.
http://www.scienceguide.com

A New Internet Directory and Information Service run by Scientists an=
d
Physicians for Scientists and Physicians.  After visiting the Guide, =
If
you have any suggestion for making the Guide better please let us kno=
w.
(webmaster@scienceguide.com)

The Science Guide consists of a number of different sections designed=
 to
help the scientist and physician find information on the internet and=
 to
sponsor communication between those interested in science:


NEWS SECTION

Every day the Science Guide compiles medical and research news from
national news sources around the net.  Most of the news articles are
concerned with medicine, bioscience, and physics, but all other scien=
ces
=66rom agriculture to zoology are commonly included. News sources cur=
rently
listed include: CNN, EurekAlert, HMS Beagle, MSNBC Sci-Tech, Science
Magazine=B9s ScienceNow, CBS Space News, USA Today, The Albuquerque J=
ournal,
Scientific American Web Weekly, The Why Files, Discover Magazine,
Scientific American, Smithsonian Magazine, and the Technology Review.=
  The
news pages also list links to news sources not compiled within the Ne=
ws
site.  We are currently working on adding a number of other sources t=
o the
site to make it even more useful.

To make getting science news even easier, we send out a DAILY NEWS EM=
AILER
listing the articles which have been compiled on our site.  Anyone ca=
n
subscribe to the Emailer by sending an email to news@scienceguide.com=
 with
the message =B3Subscribe=B2


DIRECTORY OF USENET NEWS GROUPS and DISCUSSION LISTS

The Directory of Usenet and Discussion Groups is compiled quarterly f=
rom
different sources around the net to provide the scientist and those
interested in science easy access to these invaluable sources of disc=
ourse
and information.  We are currently working on finding the proper
subscription method for each of the discussion lists.  This is taking=
 a
bit longer that we thought so please pardon our dust.  The Usenet por=
tions
of this section are complete.


ON-LINE JOURNAL HYPERLINK SECTION

The Journals Section contains links to peer reviewed scientific journ=
als
on the Internet.  Each listing clearly indicates whether the journal
provides only the table of contents, TOC with abstracts, or the full =
text
of the journal


EMPLOYMENT SECTION

The Jobs and Positions Section contains hyperlinks to the best Scient=
ific
Employment Databases and Classifieds on the net.


GRANTS and FUNDING SECTION

The funding section contains links to the best funding and grant data=
bases
on the Internet, making it very easy for scientists to quickly find
funding opportunities.  The featured site of the section is =B3The Co=
mmunity
of Science,=B2 a Johns Hopkins service designed to help scientists fi=
nd and
continue funding.


From owner-7tms_r@net.bio.net Sat Oct 11 23:00:00 1997
Path: biosci!biosci!not-for-mail
From: BIOSCI Administrator <biohelp@net.bio.net>
Newsgroups: bionet.molbio.proteins.7tms_r
Subject: BIOSCI/bionet miniFAQ & Fundraiser
Date: 12 Oct 1997 09:30:58 -0700
Organization: BIOSCI International Newsgroups for Molecular Biology
Lines: 232
Sender: daemon@net.bio.net
Approved: lfk@gcrdb.uthscsa.edu
Distribution: world
Message-ID: <61qu02$3eb@net.bio.net>
NNTP-Posting-Host: net.bio.net

(LAST REVISION: 30-JUL-95)

This BIOSCI "miniFAQ" is designed to answer the questions that come up
the *most frequently*.  The main BIOSCI FAQ (Frequently Asked
Questions) is accessible on the World Wide Web at URL
http://www.bio.net/.

If you can not find an answer to your question in this or other
documentation, the BIOSCI technical support staff answers e-mail
queries sent to

		       biosci-help@net.bio.net

We can only answer questions about the use of the newsgroups and
mailing lists.  We unfortunately do not have the staff to do Internet
information searches or answer scientific questions.  Please post
those to the appropriate BIOSCI/bionet newsgroups.


	Contents:
	--------
	0) BIOSCI NEEDS YOUR SUPPORT!!

	1) Using the WWW to access the BIOSCI/bionet newsgroups.

	2) What to do about "spams," i.e., junk mail, ads, etc.

	3) Examples of subscribing and unsubscribing to the mailing lists.

	4) The BIOSCI user address and research interest directory.


0) BIOSCI NEEDS YOUR SUPPORT!!
- ------------------------------
BIOSCI's government funding has been expended, and we are now
operating solely from advertising revenue that we have raised from our
Web site at http://www.bio.net/.  We need just a few minutes of your
time to help us serve you.

You can do two important things which will take very little time for
you individually and will immensely help us continue to help you.

First, please use our WWW system at http://www.bio.net/ to access the
archives.  You can post or reply to messages via your Web browser as
described in item #1 below.  Your usage helps attract sponsors. If you
contact any of our sponsors, please be sure to thank them for
supporting BIOSCI. It is critical for them to get this feedback if
they are to continue their sponsorship for the long term.

Second, if you work for a company or organization that provides
products or services of interest to the biology community, please pass
this message on to your marketing or marketing communications
department or other appropriate group.  Please ask them to help
support BIOSCI by sponsoring our Web site and explain the uses and
benefits of the system to the biology community. If they are
interested, they can then contact us for further information at our
tech support address, biosci-help@net.bio.net.


1) Using the WWW to access the BIOSCI/bionet newsgroups.
- --------------------------------------------------------
As of 10 December 1995, all BIOSCI/bionet full newsgroups are
accessible through the World Wide Web (WWW) at URL http://www.bio.net.
One can read and reply publicly or privately to both recent postings
and archived messages through one's Web browser if it is configured
properly to send e-mail.  Each newsgroup is equipped with its own WAIS
index.  The main BIOSCI home page also has access to the BIO-JOURNALS
Table of Contents database WAIS index and the BIOSCI user address
database described in another item further below.


2) What to do about "spams," i.e., junk mail, ads, etc.
- -------------------------------------------------------
BIOSCI is a set of parallel USENET newsgroups (the "bionet" groups),
mailing lists, and a hypermail archive at URL http://www.bio.net/.
The same postings are distributed on all media (except for a small
number of mailing-list-only groups at net.bio.net).  Unfortunately it
is becoming a despicable practice on the Internet (by a few people out
to make a fast buck) to do automated mass postings to thousands of
newsgroups and mailing lists.  These attempts to grab free advertising
are refered to as "spams" in the usual, somewhat boneheaded, net
terminology.  USENET is more susceptible to this practice, and many
spams originate on the USENET groups and then are passed on to the
mailing lists.  However, spammers also get lists of mailing addresses
and hit these too, so neither medium is immune.

What should you do personally if you get junk mail?
- ---------------------------------------------------
Just delete it and move on without reading it further.  Filing a
protest is becoming increasingly useless because spammers are often
disguising the addresses where the messages are sent from.  Unless you
really understand Internet mail systems, your attempt at protest by
sending replies to the message will often end up being sent to the
address of an innocent person that the spammer is victimizing.

What can BIOSCI/bionet do to protect its newsgroups?
- ----------------------------------------------------
The only solution currently available is to moderate the newsgroup.
If this newsgroup is already moderated, then you are in good shape.
Moderation protects the USENET distribution from about 95% of the
spams that are being sent to date and protects the mailing lists
completely.  Moderation means, however, that someone has to take the
time to review each message before it goes out.  We have set up
software here that simply allows the moderator to forward to an
address at net.bio.net messages that (s)he wishes to have distributed.
This takes no more time than that needed to read the message and pass
it on, say about 1 min. per message.

Most newsgroups currently have a discussion leader who is responsible
for their newsgroup.  The discussions leaders and their e-mail
addresses are listed in the BIOSCI Information Sheet which is
available on the Web at http://www.bio.net/.  If a newsgroup is being
hit with too many junk postings, please contact the discussion leader
for that group and see if there is interest in moderating the group.
Please do not assume that by simply posting a complaint to the
newsgroup itself, anyone on the BIOSCI staff will act on your
complaint.  With close to 100 newsgroups to run, the BIOSCI staff has
to rely on the discussion leaders of each newsgroup to report problems
directly to us at biosci-help@net.bio.net.

We will moderate any of our newsgroups if the discussion leader tells
us that the readership of the group wishes to do so and if a moderator
is willing to do the work.  For most BIOSCI/bionet groups, this
entails only a few minutes of work each day.

Moderating a newsgroup will resolve probably 95% of the junk postings
on the USENET distribution.  Unfortunately there are easy ways for
determined spammers to override the moderation mechanism on USENET,
but we can protect our e-mail subscribers from unwanted postings if
the newsgroup is moderated.  You can also access our newsgroups over
the WWW at URL http://www.bio.net.  While this Web interface will not
stop spammers from trying to post to the groups, this will give you
yet another way, besides using USENET news, to keep the junk out of
your personal mail files.  For those of you with local USENET news
systems, the Web interface will also give you faster access to new
newsgroups and recent postings.


3) Examples of subscribing and unsubscribing to the mailing lists.
- ------------------------------------------------------------------
PLEASE NOTE: The BIOSCI management does NOT act on
subscription/unsubscription requests that are posted improperly to the
newsgroups and mailing lists.  People who do this only bother everyone
on the lists to no avail.  Please be sure to follow the proper
procedures below.

Gory details are in the BIOSCI Information sheets on the Web at
http://www.bio.net.  Below we give an example utilizing the
METHODS-AND-REAGENTS list at both of our two BIOSCI sites:

Users in the Americas and Pacific Rim countries who use the BIOSCI
- ------------------------------------------------------------------
node at computer net.bio.net:
- ----------------------------

A) Determine the "listname" which is the <=8 character mail address
                                         ^^^^^^^^^^^^^
   for the group.  These can be found in the BIOSCI Info. Sheet.  For
   the METHODS-AND-REAGENTS group the mailing address is
   methods@net.bio.net.  The listname is the portion of the address to
   the left of the @ sign, i.e., "methods".  The listname is used with
   the "subscribe" and "unsubscribe" commands illustrated below.

B) Mail all commands in the body of a mail message addressed to
   biosci-server@net.bio.net.  Do NOT send commands to the newsgroup
   posting addresses!  Leave the Subject: line blank, any text on it
   will be ignored.

C) In the body of your message put one or more of the following
   commands with an "end" command on the last line, e.g.,

   subscribe methods
   unsubscribe methods
   end

   Do NOT put your e-mail address or other text on these lines.  The
   server only allows you to cancel your subscription if the address
   on your mail header matches the address on our mailing list.
   Please ask for help at biosci-help@net.bio.net if your address has
   changed, e.g., if you know you are on the list but the server tells
   you that you are not a member.


Users in Europe, Africa, and Central Asia who use the BIOSCI node at
- --------------------------------------------------------------------
computer daresbury.ac.uk (also known as dl.ac.uk):
- -------------------------------------------------

To subscribe and unsubscribe to/from the BIOSCI lists, you need to
specify the full USENET newsgroup name with "bionet-news." prepended.
The USENET newsgroup names are listed in the BIOSCI Information sheet
on the Web at http://www.bio.net/.  For the METHODS-AND-REAGENTS list
the USENET newsgroup name is bionet.molbio.methds-reagnts, thus the
appropriate commands are

    sub bionet-news.bionet.molbio.methds-reagnts

    unsub bionet-news.bionet.molbio.methds-reagnts

These commands are included in a message addressed to mxt@dl.ac.uk,
NOT to the newsgroup mailing addresses.  As usual, include the text in
the body of the message as text on the Subject: line is ignored.

To unsubscribe from all the lists at the UK node, use

    unsub bionet-news

Please note that if the address in the list is different than the one
in your mail message header, you will not be able to unsubscribe by
this method. If you have problems, please mail biosci@daresbury.ac.uk.


4) The BIOSCI user address and research interest directory.
- -----------------------------------------------------------
Please take this opportunity to add your name, address, and research
interest information to the BIOSCI User Address Database if you have
not already done so.

You can fill out the address form directly through our Web page at URL
http://www.bio.net/adrform.html.

The address database is reindexed nightly for WWW access (the URL is
http://www.bio.net/).  If you are not directly on the Internet but can
reach it by e-mail, please use our waismail server to access the user
directory.  waismail use is described above.  You can also request a
user address form by e-mail from biosci-help@net.bio.net.

Please check your database entry from time-to-time to see if your
address information is still up-to-date.  Because of our limited
personnel resources, we ask that you resubmit a *complete* form to
revise your entry; we only replace complete entries and do not have
resources to edit old forms.

From owner-7tms_r@net.bio.net Wed Oct 15 23:00:00 1997
Path: biosci!biosci!not-for-mail
From: steph angers <sanger@po-box.mcgill.ca>
Newsgroups: bionet.molbio.proteins.7tms_r
Subject: Endogenous cAMP Levels
Date: 16 Oct 1997 15:22:23 -0700
Organization: BIOSCI International Newsgroups for Molecular Biology
Lines: 13
Sender: daemon@net.bio.net
Approved: lfk@gcrdb.uthscsa.edu
Distribution: world
Message-ID: <62642v$4lq@net.bio.net>
NNTP-Posting-Host: net.bio.net

HI,

I was wondering if anyone knew the different endogeneous cAMP levels for
different cell lines,

like CHO, COS, HELA, BHK, 293.....

Thanks,

Stephane Angers
Biosignal Inc.
research@biosignal.com
------- End of forwarded message -------

From owner-7tms_r@net.bio.net Thu Oct 16 23:00:00 1997
Path: biosci!biosci!not-for-mail
From: Bruno Cenni <Bruno.Cenni@cellbio.unige.ch>
Newsgroups: bionet.molbio.proteins.7tms_r
Subject: D1 receptor antibody
Date: 17 Oct 1997 06:06:30 -0700
Organization: University of Geneva
Lines: 23
Sender: daemon@net.bio.net
Approved: lfk@gcrdb.uthscsa.edu
Distribution: world
Message-ID: <627nsm$3q5@net.bio.net>
NNTP-Posting-Host: net.bio.net

Hi all,

does anyone know a source for an antibody against human dopamine D1
receptors, possibly one that works in immunihistochemistry? We are
trying to screen cell lines for presence or absence of D1DR.

Thanks

Bruno

 
*******************************************************************
Bruno Cenni Ph.D.
University of Geneva
Dept. of Cell Biology
Sciences III
30 Quai Ernest Ansermet
1211 Geneva 4
Switzerland
Phone: ++41 22 702 6811
Fax:     ++41 22 702 6442
cenni@cellbio.unige.ch
<http://www.unige.ch/sciences/biologie/bicel/welcome.html>

From owner-7tms_r@net.bio.net Thu Oct 16 23:00:00 1997
Path: biosci!biosci!not-for-mail
From: Michael Levine <mlevine@welchlink.welch.jhu.edu>
Newsgroups: bionet.molbio.proteins.7tms_r
Subject: somatostatin receptor
Date: 17 Oct 1997 12:39:00 -0700
Organization: BIOSCI International Newsgroups for Molecular Biology
Lines: 4
Sender: daemon@net.bio.net
Approved: lfk@gcrdb.uthscsa.edu
Distribution: world
Message-ID: <628esk$mns@net.bio.net>
NNTP-Posting-Host: net.bio.net

Does anyone have a good antiserum for the type 2 somatostatin receptor that
can be used for immunocytochemistry?

Michael Levine

From owner-7tms_r@net.bio.net Fri Oct 17 23:00:00 1997
Path: biosci!biosci!not-for-mail
From: newsmgr@merrimack.edu
Newsgroups: bionet.molbio.proteins.7tms_r
Subject: Gq and Bkt?
Date: 18 Oct 1997 14:09:33 -0700
Organization: BIOSCI International Newsgroups for Molecular Biology
Lines: 20
Sender: daemon@net.bio.net
Approved: lfk@gcrdb.uthscsa.edu
Distribution: world
Message-ID: <62b8id$t7n@net.bio.net>
NNTP-Posting-Host: net.bio.net

Relay-Version: ANU News - V6.2.0 06/23/97 OpenVMS AXP V6.2; site chasm
Path: chasm!cam-news-feed2.bbnplanet.com!cam-news-hub1.bbnplanet.com!cpk-news-hub1.bbnplanet.com!news.bbnplanet.com!mindspring!news.mindspring.com!usenet
Newsgroups: bionet.molbio.proteins.7tms_r
Subject: Gq and Bkt?
Message-ID: <3448E003.AEAE3BD0@emory.edu>
From: Rick Bright <rbright@emory.edu>
Date: Sat, 18 Oct 1997 12:12:51 -0400
Organization: Emory University, Molecular Therapeutics & Toxicology
Lines: 5
NNTP-Posting-Host: user-38lcamc.dialup.mindspring.com
Mime-Version: 1.0
Content-Type: text/plain; charset=us-ascii
Content-Transfer-Encoding: 7bit
X-Server-Date: 18 Oct 1997 16:13:55 GMT
X-Mailer: Mozilla 4.03 [en] (Win95; U)

Does anyone know of the relation between Gq and Bkt kinase?  I would
appreciate any references.

Thanks

From owner-7tms_r@net.bio.net Fri Oct 24 23:00:00 1997
Path: biosci!biosci!not-for-mail
From: "Christophe GUENIN" <christophe.guenin@hol.fr>
Newsgroups: bionet.molbio.proteins.7tms_r
Subject: Cellular adherence
Date: 25 Oct 1997 11:28:01 -0700
Organization: None
Lines: 5
Sender: daemon@net.bio.net
Approved: lfk@gcrdb.uthscsa.edu
Distribution: world
Message-ID: <62tdnh$bai@net.bio.net>
NNTP-Posting-Host: net.bio.net

I have a cellular adherence problem when I am doing fluorescence in glass
slide with polylysine with transfected cell cos7. My cellular cover is
damaged when i'm washing it and /or antibody marquage.
You can reply in this news group or at the following e mail :
christophe.guenin@hol.fr

From owner-7tms_r@net.bio.net Sat Oct 25 23:00:00 1997
Path: biosci!biosci!not-for-mail
From: daemon@net.bio.net
Newsgroups: bionet.molbio.proteins.7tms_r
Subject: Updated WWWsite:  The Antibody Resource Page
Date: 26 Oct 1997 14:51:24 -0800
Organization: BIOSCI International Newsgroups for Molecular Biology
Lines: 61
Approved: lfk@gcrdb.uthscsa.edu
Distribution: world
Message-ID: <630hhc$chg@net.bio.net>
NNTP-Posting-Host: net.bio.net

Relay-Version: ANU News - V6.2.0 06/23/97 OpenVMS AXP V6.2; site chas=
m
Path: chasm!cam-news-feed2.bbnplanet.com!cam-news-hub1.bbnplanet.com!=
news.bbnplanet.com!news.maxwell.syr.edu!newsfeed.internetmci.com!131.=
103.1.114!iagnet.net!nntp.earthlink.net!usenet
Newsgroups: bionet.molbio.proteins.7tms_r
Subject: Updated WWWsite:  The Antibody Resource Page
Message-ID: <3453464A.12C0@znet.com>
=46rom: kshreder@znet.com
Date: Sun, 26 Oct 1997 05:31:54 -0800
Reply-To: kshreder@znet.com
Organization: The Antibody Resource Page
Lines: 34
NNTP-Posting-Host: 153.35.100.12
Mime-Version: 1.0
Content-Type: text/plain; charset=3Diso-8859-1
Content-Transfer-Encoding: 8bit
X-Mailer: Mozilla 3.0Gold (Win16; U)

Updated WWWsite:  The Antibody Resource Page

The Antibody Resource Page has been recently updated.  The page will =
be
invaluable to researchers and educators alike.

Here is just some of what can be found on the page:

1. How to Find an Antibody - a variety of ways on and off the web to
find the antibody you are looking for.

2. Online Companies - links to over 110 companies that sell antibodie=
s
or antibody related products.  Is your company listed on this page?

3. Antibody Image Gallery - some animated gifs have recently been add=
ed

4. Bulletin Board - Have a question or have an answer?  Then stop by =
and
post a message.

5. Educational Resources - a variety of new links have been added.=
=20
There are links to pages on immunochemistry, antibody production,=
=20
autoimmunity, vaccines, immunology and much more.  This page is divid=
ed
up into sections on research, educational, and health resources.

6. The Latest in Antibody News - Get up-to-date, antibody-related
articles on topics from academia and industry.

=2E..and there is much more.  Check it out at:

http://www.antibodyresource.com/


Ps.  Don=92t forget to visit our sponsors, Research Diagnostics, Inc.
(http://www.researchd.com/absort1.htm) and Lab Vision Corporation
(http://www.labvision.com/)!


